tiprankstipranks
OncoCyte Corp (DE:7OC)
FRANKFURT:7OC

OncoCyte (7OC) Financial Statements

0 Followers

OncoCyte Financial Overview

OncoCyte's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; OncoCyte is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 297.00K$ -3.55M$ 1.02M$ 2.07M$ 1.42M
Gross Profit$ 10.00K$ 2.00M$ -1.17M$ -314.00K$ -533.00K
EBIT$ 5.97M$ 9.32M$ -9.32M$ -8.28M$ -10.26M
EBITDA$ 5.52M$ 8.49M$ -7.95M$ -6.92M$ -9.05M
Net Income Common Stockholders$ 1.63M$ -45.29M$ -9.55M$ -8.37M$ -10.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.40M-$ 32.47M$ 45.41M$ 20.99M
Total Assets$ 82.80M-$ 157.34M$ 171.05M$ 146.27M
Total Debt$ 0.00$ 0.00$ 3.76M$ 4.55M$ 5.12M
Net Debt$ -12.40M$ 0.00$ -28.71M$ -40.87M$ -15.87M
Total Liabilities$ 39.34M-$ 80.49M$ 82.95M$ 89.31M
Stockholders Equity$ 37.93M-$ 76.86M$ 88.10M$ 56.97M
Cash Flow-
Free Cash Flow$ 8.67M$ -10.45M$ -12.21M$ -12.41M$ -14.84M
Operating Cash Flow$ 8.67M$ -9.65M$ -11.35M$ -11.29M$ -13.28M
Investing Cash Flow$ -18.31M$ -802.00K$ -859.00K$ -1.12M$ -1.56M
Financing Cash Flow$ -28.00K$ -100.00K$ -572.00K$ 36.83M$ -355.00K
Currency in USD

OncoCyte Earnings and Revenue History

OncoCyte Debt to Assets

OncoCyte Cash Flow

OncoCyte Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis